Carotid endarterectomy (CEA) is a surgical procedure used to treat carotid artery stenosis, a narrowing of the carotid artery which can lead to stroke. CEA is a minimally invasive procedure that involves the removal of plaque buildup from the artery wall. The procedure has been used for decades to treat carotid artery stenosis, but advances in technology have revolutionized the way CEA is performed. This article will discuss the new techniques and technologies that are revolutionizing CEA and how they are improving the safety and efficacy of this procedure for stroke prevention.
Carotid endarterectomy is a surgical procedure used to treat carotid artery stenosis, a narrowing of the carotid artery which can lead to stroke. During the procedure, the surgeon makes an incision in the neck and then removes the plaque buildup from the artery wall. The procedure is usually done under general anesthesia, and the patient is usually discharged from the hospital the same day.
Carotid endarterectomy has been used for decades to treat carotid artery stenosis, but advances in technology have revolutionized the way CEA is performed. These advances have improved the safety and efficacy of the procedure, making it a more attractive option for stroke prevention. The main advantage of CEA is that it can reduce the risk of stroke by removing the plaque buildup from the artery wall. This reduces the risk of blood clots forming and blocking the artery, which can cause a stroke. CEA is also less invasive than other treatments, such as angioplasty and stenting, and can be performed in less time.
There have been several advances in technology and techniques that have revolutionized the way CEA is performed. These advances include: • Ultrasound imaging: Ultrasound imaging is used to create a detailed image of the carotid artery and the plaque buildup. This allows the surgeon to accurately identify the location and extent of the stenosis. • Endovascular stenting: Endovascular stenting is a minimally invasive procedure that uses a catheter to place a stent in the carotid artery. This helps to keep the artery open and reduce the risk of stroke. • Laser ablation: Laser ablation is a minimally invasive procedure that uses a laser to remove plaque buildup from the artery wall. • Robotic surgery: Robotic surgery is a minimally invasive procedure that uses a robotic arm to perform the procedure. This allows for more precise and accurate placement of the stent or laser ablation.
The new techniques and technologies used in CEA have improved the safety and efficacy of the procedure. Ultrasound imaging allows for more accurate placement of the stent or laser ablation, reducing the risk of complications. Endovascular stenting and laser ablation are less invasive than traditional CEA, reducing the risk of infection and other complications. Robotic surgery is more precise and accurate than traditional CEA, reducing the risk of damage to the artery wall.
Carotid endarterectomy is a surgical procedure used to treat carotid artery stenosis, a narrowing of the carotid artery which can lead to stroke. Advances in technology and techniques have revolutionized the way CEA is performed, improving the safety and efficacy of the procedure. Ultrasound imaging, endovascular stenting, laser ablation, and robotic surgery are all new techniques and technologies that are improving the safety and efficacy of CEA for stroke prevention.
1.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
2.
FDA approves Blenrep for relapsed or refractory multiple myeloma
3.
X-ray and radar technology combined to reduce cancer screening risks
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Researchers discuss HER2-low and HER2-zero in breast cancer
1.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
2.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
3.
The New Era of Oncology: Key Updates and Clinical Insights
4.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation